Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic Influenza Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00532792
What this trial is testing

A/H5N1 Dose Ranging Study With Adjuvant Patch

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 501
Testing effectiveness (Phase 2)Study completedNCT00481065
What this trial is testing

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

Who this might be right for
PandemicAvian Influenza
Novartis 405
Testing effectiveness (Phase 2)Study completedNCT00561184
What this trial is testing

Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

Who this might be right for
Avian Influenza
Novartis Vaccines 47
Early research (Phase 1)Study completedNCT00853255
What this trial is testing

Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00545701
What this trial is testing

Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT00488046
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 16
Testing effectiveness (Phase 2)UnknownNCT01055990
What this trial is testing

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Who this might be right for
Virus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more
Shanghai Public Health Clinical Center 7
Early research (Phase 1)Study completedNCT01059617
What this trial is testing

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

Who this might be right for
Influenza
GlaxoSmithKline 133
Not applicableStudy completedNCT07601126
What this trial is testing

Respiratory Pathogen Distribution During and After the COVID-19 Pandemic

Who this might be right for
Viral Respiratory Infection (e.g., Influenza)Bacterial Respiratory Infections
Hisar Intercontinental Hospital 537
Not applicableStudy completedNCT01394640
What this trial is testing

Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients

Who this might be right for
LymphomaMultiple MyelomaMyeloproliferative Disease
Paolo Corradini 124
Large-scale testing (Phase 3)Active Not RecruitingNCT07496450
What this trial is testing

MRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 4,050
Testing effectiveness (Phase 2)WithdrawnNCT00989274
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Who this might be right for
Influenza
Instituto Nacional de Salud Publica, Mexico
Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Testing effectiveness (Phase 2)Ended earlyNCT01003418
What this trial is testing

Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 8
Not applicableStudy completedNCT01056354
What this trial is testing

Respiratory Virus Outpatient Study (FLU 002 Plus)

Who this might be right for
Influenza and Other Novel Respiratory Viruses
University of Minnesota 11,719
Large-scale testing (Phase 3)WithdrawnNCT00866580
What this trial is testing

Evaluation of GSK Biologicals' Pandemic Influenza Vaccine

Who this might be right for
Influenza
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00976469
What this trial is testing

A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 400
Early research (Phase 1)Study completedNCT06179446
What this trial is testing

Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Who this might be right for
GrippeInfluenzaVaccines
Pfizer 157
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Early research (Phase 1)Study completedNCT00812019
What this trial is testing

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Who this might be right for
Influenza
Seqirus 753
Next Page